Influenza Vaccines Available in India
In India, both trivalent (IIV3) and quadrivalent (IIV4) inactivated influenza vaccines are available, with quadrivalent vaccines offering broader protection against circulating influenza B viruses and therefore being the preferred option for vaccination.
Types of Influenza Vaccines in India
Quadrivalent Inactivated Influenza Vaccines (IIV4)
Fluzone Quadrivalent (Sanofi Pasteur) - Available for individuals aged ≥6 months 1
- Demonstrated good immunogenicity and safety profile in Indian children, adolescents, and adults
- Available in different dose formulations: 0.25 mL for children 6-35 months and 0.5 mL for individuals ≥36 months
Influvac Tetra (Abbott) - Available for adults and elderly 2
- Demonstrated adequate immune response with favorable safety profile in Indian adults and elderly
VaxiFlu-4 (Zydus Cadila Healthcare) - Available for adults and elderly 2
- Comparable immunogenicity and safety profile to Influvac Tetra
Trivalent Inactivated Influenza Vaccines (IIV3)
While less commonly used now, trivalent vaccines have been available in India and may still be found in some settings 3.
Formulations and Administration
Age-Specific Dosing
Administration Route
- Most influenza vaccines are administered intramuscularly 4
- For adults and older children, the deltoid is the preferred site
- For infants and younger children, the anterolateral thigh is recommended
Timing of Vaccination in India
The Indian Academy of Pediatrics (IAP) recommends that the ideal time for offering influenza vaccines in India is just before the onset of the rainy season 3:
- June to August for most regions of India
- October to December for Tamil Nadu
Vaccine Composition
Quadrivalent vaccines contain:
- Two influenza A strains (H1N1 and H3N2)
- Two influenza B strains (Victoria and Yamagata lineages)
This composition provides broader protection compared to trivalent vaccines, which contain only one B lineage strain 4.
Safety Profile
- Most common injection site reactions: pain, redness, and swelling 1, 5
- Most common systemic reactions:
- Fever (especially in children 6-23 months)
- Myalgia in older children and adolescents
- Headache, fatigue, and mild gastrointestinal symptoms 1
- Most reactions are mild to moderate (grade 1 or 2) and resolve within 3 days 1
Special Considerations
Egg Allergy
Most influenza vaccines are manufactured using egg-based technology and may contain residual egg protein. However, individuals with egg allergy can typically receive influenza vaccines with appropriate precautions 4.
Vaccine Effectiveness
The effectiveness of influenza vaccines depends on the match between vaccine strains and circulating viruses. Quadrivalent vaccines offer improved protection against circulating B viruses compared to trivalent vaccines 6.
Current Recommendations
The Indian Academy of Pediatrics recommends influenza vaccination for children with risk factors but not as a universal measure 3. Priority groups have been identified based on:
- Contribution to overall influenza burden
- Disease severity
- Vaccine effectiveness in different age groups and categories
Conclusion
Quadrivalent influenza vaccines are now widely available in India and offer broader protection than trivalent vaccines. The choice of vaccine should be based on age, availability, and individual risk factors.